GGrantIndex
← Leaderboards

Daniel J Weiss

Fred Hutchinson Cancer Research Center

Google Scholar ↗PubMed ↗ORCID ↗
$9,545,854
Attributed
$10,149,185
Total exposure
23
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,149,185 · 23

By mechanism

RC4$4,255,543 · 1
R21$2,759,162 · 7
R01$1,525,000 · 1
R33$748,000 · 1
K08$366,120 · 1
R13$275,099 · 9

Top collaborators

Others in their field

Top investigators on “Lung”

Research focus

LungCellsStem CellsBiomedical EngineeringLung DiseasesNatural RegenerationLung InjuryFutureInduced Pluripotent Stem CellRepairedBaseInjuryScaffoldInnovationMeetingsUnited States National Institutes Of HealthUniversitiesCystic FibrosisResearch PersonnelEpithelial CellsCell TherapyEpithelialLung DevelopmentAdult

Grant awards (36)

Continued Clinical Development of a Novel Pleural and Tracheal Sealant$367,000
R33 · FY2025 · HL · contact PI
Extracellular Matrix Regulation of Airway Epithelial Homeostasis$229,200
R21 · FY2025 · HL · contact PI
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases$35,000
R13 · FY2025 · HL · contact PI
Continued Clinical Development of a Novel Pleural and Tracheal Sealant$381,000
R33 · FY2024 · HL · contact PI
Extracellular Matrix Regulation of Airway Epithelial Homeostasis$203,974
R21 · FY2024 · HL · contact PI
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases$35,000
R13 · FY2023 · HL · contact PI
Ex vivo bioengineering of functional biomimetic airways for treatment of neonatal and pediatric respiratory conditions$247,743
R21 · FY2022 · HD
Ex vivo bioengineering of functional biomimetic airways for treatment of neonatal and pediatric respiratory conditions$231,527
R21 · FY2021 · HD
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases$30,000
R13 · FY2021 · HL · contact PI
Zeta View TWIN Laser Nanoparticle Tracking Analyzer$122,058
S10 · FY2019 · OD · contact PI
Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases$30,000
R13 · FY2019 · HL · contact PI
Optimizing Functional Recellularization of Acellular Human Lung Scaffolds$381,250
R01 · FY2018 · HL · contact PI
Decellularized Avian Lungs for Use in Pulmonary Therapeutics$234,000
R21 · FY2018 · EB · contact PI
Optimizing Functional Recellularization of Acellular Human Lung Scaffolds$381,250
R01 · FY2017 · HL · contact PI
Decellularized Avian Lungs for Use in Pulmonary Therapeutics$194,218
R21 · FY2017 · EB · contact PI
Stem Cell, Cell Therapies and Bioengineering in Lung Biology and Lung Diseases$30,000
R13 · FY2017 · HL · contact PI
Optimizing Functional Recellularization of Acellular Human Lung Scaffolds$381,250
R01 · FY2016 · HL · contact PI
Optimizing Functional Recellularization of Acellular Human Lung Scaffolds$381,250
R01 · FY2015 · HL · contact PI
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology in Lung Diseases Conference$30,000
R13 · FY2015 · HL · contact PI
Stem Cells and Cell Therapies in Lung Biology and Diseases$5,000
R13 · FY2013 · HL · contact PI
De-Cellularized Human Lungs for Ex Vivo Lung Regeneration$215,886
R21 · FY2012 · HL · contact PI
De-Cellularized Human Lungs for Ex Vivo Lung Regeneration$182,597
R21 · FY2011 · HL · contact PI
Stem cells and cell therapies in lung biology and diseases$30,099
R13 · FY2011 · HL · contact PI
Bioengineering New Lungs from Cadaveric Lung Scaffolds$4,255,543
RC4 · FY2010 · HL · contact PI
Use of 3-D Culture and Stretch to Develop Lung from MSCs, ESCs, and iPS$189,375
R21 · FY2010 · HL · contact PI
Stem Cells and Cell Therapies in Lung Biology and Diseases$25,000
R13 · FY2009 · HL · contact PI
Mechanisms of Marrow-Derived Stem Cell Remodeling of Aged Emphysematous Lungs$228,000
R21 · FY2008 · HL · contact PI
Mechanisms of Marrow-Derived Stem Cell Remodeling of Aged Emphysematous Lungs$190,000
R21 · FY2007 · HL · contact PI
Stem Cells and Cellular Therapies in Lung Biology and Lung Diseases$25,000
R13 · FY2007 · HL · contact PI
Role of IL-17 in Recruitment of Adult Stem Cells to Lung$222,642
R21 · FY2006 · HL · contact PI
Role of IL-17 in Recruitment of Adult Stem Cells to Lung$190,000
R21 · FY2005 · HL
PERFLOROCARBON-ENHANCED GENE DELIVERY TO PRIMATE LUNG$45,004
P51 · FY2004 · RR
PERFLOROCARBON-ENHANCED GENE DELIVERY TO PRIMATE LUNG$53,199
P51 · FY2003 · RR
FLUOROCARBON ENHANCED GENE DELIVERY TO AIRWAY EPITHELIUM$126,360
K08 · FY2002 · HL
FLUOROCARBON ENHANCED GENE DELIVERY TO AIRWAY EPITHELIUM$126,360
K08 · FY2001 · HL
FLUOROCARBON ENHANCED GENE DELIVERY TO AIRWAY EPITHELIUM$113,400
K08 · FY2000 · HL